Henry Schein, Inc. is rated a Buy with solid growth, strong Q3 revenue & improved profitability across all segments. Learn ...

Henry Schein (HSIC) announced the expansion of its agreement with vVARDIS, which grants the company exclusive U.S. distribution rights for the ...

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Henry Schein HSIC is well positioned to gain from its extensive global foothold and diverse channel mix. Yet, global economic uncertainties are concerns for Henry Schein. The stock carries a Zacks ...

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 22,000 Team Schein Members worldwide, the Company's ...

The growth in the healthcare distribution industry is a positive sign for Henry Schein’s business, indicating growing awareness of the benefits of preventative care and oral hygiene. The company’s ...

Henry Schein, Inc. HSIC registered adjusted earnings per share (EPS) of 66 cents in the fourth quarter of 2023, down 51.1% from the year-ago period’s adjusted EPS. The metric also lagged the Zacks ...

Faced with mounting support for an unsupervised midlevel provider (MLP) model at both the state and national levels, the Washington State Dental Association is taking matters into its own hands by ...

Detailed price information for Henry Schein Inc (HSIC-Q) from The Globe and Mail including charting and trades.